Persantine and Adalat cc drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Persantine (dipyridamole) and Adalat cc (nifedipine). Common drug interactions include blood albumin decreased among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Persantine and Adalat cc. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Persantine?

Persantine has active ingredients of dipyridamole. eHealthMe is studying from 2,427 Persantine users. Check the latest studies of Persantine.

What is Adalat cc?

Adalat cc has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 5,019 Adalat cc users. Check the latest studies of Adalat cc.



On Jul, 04, 2026

22 people who take Persantine and Adalat cc together, and have interactions are studied.

Persantine and Adalat cc drug interactions.

What are the common drug interactions of Persantine and Adalat Cc, by gender? *:

female:

  1. Blood albumin decreased
  2. Blood calcium decreased
  3. Blood creatinine increased
  4. Osteonecrosis (death of bone)
  5. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  6. Protein total decreased
  7. White blood cell count increased
  8. Coronary artery restenosis (recurrence of narrowing of artery)
  9. Vessel puncture site haemorrhage (vessel puncture site bleeding)

male:

  1. Pyrexia (fever)
  2. Interstitial lung disease
  3. Red blood cell count decreased
  4. White blood cell count increased
  5. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  6. Acetone urine present
  7. Alanine aminotransferase increased
  8. Anaemia (lack of blood)
  9. Anorectal disorder
  10. Apnoea (suspension of external breathing)

What are the common drug interactions of Persantine and Adalat Cc, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blood albumin decreased
  2. Blood calcium decreased
  3. Blood creatinine increased
  4. Osteonecrosis (death of bone)
  5. Protein total decreased
  6. White blood cell count increased

50-59:

n/a

60+:

  1. Pyrexia (fever)
  2. Interstitial lung disease
  3. Red blood cell count decreased
  4. White blood cell count increased
  5. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  6. Acetone urine present
  7. Alanine aminotransferase increased
  8. Anaemia (lack of blood)
  9. Anorectal disorder
  10. Apnoea (suspension of external breathing)

What are the existing conditions these people have? *

  1. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 3 people, 13.64%
  2. Diabetes: 3 people, 13.64%
  3. Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 9.09%
  4. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 9.09%
  5. Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Persantine and Adalat cc?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Persantine and Adalat cc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Persantine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Adalat cc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Persantine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Adalat cc and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dipyridamole and nifedipine (the active ingredients of Persantine and Adalat cc, respectively), and Persantine and Adalat cc (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: